CYTK
Cytokinetics, Incorporated · Healthcare
Director B Lynne Parshall sold $286K of Cytokinetics, Incorporated
Sold$286,300
$57.26Price
5,000Shares
−20%Stake
What CYTK did after the filing
- The stock from Tue, Aug 27 open, $56.73
- −4.1%
- S&P 500, same days
- +3.5%
Measured over 30 trading days, to the Oct 9 close.
Traded Mon, Aug 26. Filed Mon, Aug 26, 4:00 PM ET, after the close. Returns use the Aug 27 open and the Oct 9 close. Not investment advice.